CLIP MONEY INC CLIP 深 滬
等待開盤 05-20 09:30:00 美东时间
100.25
+0.010
+0.01%
華盛通- 最 高100.25
- 今 開100.24
- 成交量 16.89万股
- 最 低 100.23
- 昨 收 100.24
- 總市值 25.78亿
- 52周最高 100.25
- 市盈率 靜 --
- 換手率 0.66%
- 52周最低 96.463
- 委 比 -35.36%
- 總股本 2571.94万
- 歷史最高 100.25
- 量 比 0.43
- 振 幅 0.02%
- 歷史最低 86.8038
- 每 手 1
- 風險率 1.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Spain's eclipse a chance to draw holidaymakers inland, away from crowded beaches
Spain's eclipse a chance to draw holidaymakers inland, away from crowded beaches Eclipse expected to draw many tourists to rural Spain Government wants to promote inland destinations for event Hopes event will help ease overtourism on Mediterranean coast Hotel bookings in small cities on eclipse pat
05-07 14:00
Full Transcript: Firefly Aerospace Q1 2026 Earnings Call
Firefly Aerospace (NASDAQ:FLY) released first-quarter financial results and hos...
05-05 06:14
Vir posts Q4 revenue of USD 64.1 million up 5.17x
Vir posts Q4 revenue of USD 64.1 million up 5.17x Vir reported Q4 2025 revenue of USD 64.1 million and a net loss attributable to shareholders of USD 42.9 million (USD 0.31 per share). R&D expenses were USD 88.3 million and SG&A expenses were USD 23.6 million. Cash, cash equivalents and investments
02-24 06:14
BRIEF-Oxide Raised Its $200 Million Series C Led By Thomas Tull's Usit, With Participation From Eclipse, Riot Ventures, Jane Street, & More
BRIEF-Oxide Raised Its $200 Million Series C Led By Thomas Tull's Usit, With Participation From Eclipse, Riot Ventures, Jane Street, & More Feb 10 (Reuters) - OXIDE: RAISED ITS $200 MILLION SERIES C LED BY THOMAS TULL'S USIT, WITH PARTICIPATION FROM ECLIPSE, RIOT VENTURES, JANE STREET, & MORE Source
02-10 23:42
Clip Money Secures $3 Million Non-Dilutive Growth Loan from BDC
Clip Money Inc. ( ($TSE:CLIP) ) just unveiled an announcement. Clip Money Inc. ...
2025-12-18 22:18
BRIEF-Vir Biotechnology Grants Norgine Exclusive Commercial License To Chronic Hepatitis Delta Treatment Candidate
Dec 16 (Reuters) - Vir Biotechnology Inc VIR.O: VIR BIOTECHNOLOGY GRANTS NORGINE EXCLUSIVE COMMERCIAL LICENSE TO CHRONIC HEPATITIS DELTA TREATMENT CANDIDATE IN EUROPE, AUSTRALIA & NEW ZEALAND, INCLUDI...
2025-12-17 05:19
BRIEF-Eclipse Energy Announces Collaborative Partnership With Weatherford
Dec 11 (Reuters) - Eclipse Energy: ECLIPSE ENERGY ANNOUNCES COLLABORATIVE PARTNERSHIP WITH WEATHERFORD ACCELERATING COMMERCIALIZATION OF SUBSURFACE CLEAN ENERGY TECHNOLOGIES ECLIPSE ENERGY - JOINT PRO...
2025-12-11 23:03
ROI-Will Trump's Fed pick slash rates? The market doesn't think so: McGeever
By Jamie McGeever ORLANDO, Florida, Dec 8 (Reuters) - Financial pundits seem convinced that the new Federal Reserve chair will be an uber-dovish Donald Trump loyalist intent on slashing interest rates...
2025-12-08 22:04
BRIEF-Vinci Emerges From Stealth To Transform Semiconductor Design And Simulation
Dec 2 (Reuters) - VINCI EMERGES FROM STEALTH TO TRANSFORM SEMICONDUCTOR DESIGN AND SIMULATION VINCI: ANNOUNCED $46M IN TOTAL FUNDING, WITH ITS SERIES A LED BY XORA INNOVATION AND ITS SEED ROUND LED BY...
2025-12-02 21:40
AbbVie Submits Atogepant for Acute Migraine Treatment Review to European Medicines Agency
AbbVie Inc. has submitted an application to the European Medicines Agency (EMA) seeking expanded use of atogepant for the acute treatment of adults with migraine across Europe. The submission follows ...
2025-12-01 17:00
